Inactive Instrument
Calliditas Therapeutics AB Stock
Stocks
0A5R
SE0010441584
Pharmaceuticals
OTC Markets Traded| 1 day | +0.98% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 49 | 2017-07-31 | |
Lars Stubberud
CTO | Chief Tech/Sci/R&D Officer | 62 | 2023-12-31 |
| Chief Tech/Sci/R&D Officer | - | 2019-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Hensley
CHM | Chairman | 43 | - |
Yoshikazu Aoki
BRD | Director/Board Member | - | - |
Masaya Etoh
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-09-03 | Sell | Chief Executive Officer | 735,112 | 1.2338% | ||
| 24-09-03 | Sell | Chief Financial Officer | 16,250 | 0.0273% | ||
| 24-09-03 | Sell | 13,535 | 0.0227% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.98% | -0.19% | - | - | 1.16B | ||
| +4.02% | +10.17% | +57.46% | +9.47% | 298B | ||
| +4.93% | +10.48% | +33.21% | -3.89% | 69.19B | ||
| +2.09% | +5.96% | +38.83% | +112.76% | 8.44B | ||
| +0.55% | +1.40% | +3.98% | -5.80% | 8.27B | ||
| +2.31% | -0.11% | -4.11% | +4.85% | 4.4B | ||
| +4.94% | +12.50% | +7.58% | +29.39% | 3.64B | ||
| -1.38% | -8.82% | -30.10% | +29.30% | 3.5B | ||
| -0.86% | +0.83% | +43.25% | +37.14% | 2.62B | ||
| +2.36% | +10.87% | +13.02% | -20.42% | 2.07B | ||
| Average | +1.99% | +4.76% | +18.13% | +21.42% | 44.44B | |
| Weighted average by Cap. | +3.96% | +5.45% | +49.55% | +9.35% |
Employees
222
Sector
Pharmaceuticals
















